Astonea Labs Ltd IPO
Open Demat Account
Astonea Labs Ltd IPO Details
Details
| Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
|---|---|---|---|---|---|
| ₹ 27.9 L | TBA | TBA | ₹ 76 L | BSE | ₹ 37.67 Cr |
| IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
| 27 May, 25 | 29 May, 25 | 1000 | ₹ 1,28,000 | Book Building - SME | 03 Jun, 25 |
Astonea Labs Ltd IPO Dates
Details
| Sector | Type |
|---|---|
| Sector | Pharmaceuticals - Indian - Bulk Drugs |
| Sub Sector | NA |
| Issue Type | Book Building - SME |
Subscription Status
*Values are in Lakhs
| Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
|---|---|---|---|
| QIB | 0x | 0 | 0 |
| NII | 0x | 0 | 0 |
| Retail | 0x | 0 | 0 |
| Employee | 0x | 0 | 0 |
| Total | 0x | 2790000 | 0 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Astonea Labs Ltd Financial Status
Income Statement
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from operations | 9.08 | 5.01 | 4.37 |
| EBITDA | 13.05 | 8.94 | 8.16 |
| PAT | 3.81 | 0.67 | 0.25 |
| Total Assets | 54.91 | 42.55 | 30.96 |
| Share Capital | 7.60 | 4.00 | 4.00 |
| Total Borrowings | 39.26 | 34.14 | 25.49 |
| Operating Activities (Net Cash) | 7.78 | 4.60 | 4.04 |
| Investing Activities (Net Cash) | -2.10 | 0.00 | 0.00 |
| Financing Activities (Net Cash) | 39.26 | 34.14 | 25.49 |
| Net Cashflow | 0.36 | 0.04 | 0.03 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Astonea Labs Ltd
Our Company was originally incorporated as AHU Laboratories Private Limited, as a private limited company, under the provisions of the Companies Act, 2013 pursuant to certificate of incorporation dated April 11, 2017. Our Company changed its name from AHU Laboratories Private Limited to Astonea Labs Private Limited pursuant to Rule 29 of the Companies (Incorporation) Rules, 2014 vide certificate of incorporation dated February 26, 2019. Subsequently, our Company converted into Astonea Labs Limited, a public limited company vide fresh certificate of incorporation dated January 11, 2024 the Corporate Identification Number of our Company is U24304CH2017PLC041482.
India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the major segments of the Indian pharma industry. India has highest number of pharmaceutical manufacturing facilities that comply with the US Food and Drug Administration (USFDA) and has 500 API producers that make for around 8% of the worldwide API market<br /> . The Indian cosmetics sector is currently going through a phase of tremendous expansion. The market for cosmetics in India was estimated to be worth US$ 11.6 billion in 2017 and is projected to expand at a CAGR of 15-20% from 2017 to 2025. The Indian cosmetics sector is expanding for a variety of reasons. The rise of the cosmetic sector has been fuelled by rising purchasing power, rising image consciousness among Indians, and the embrace of Western culture and lifestyle. Since ancient times, India has had an extensive record and a rich tradition of cosmetics. It is currently a thriving sector, and in the upcoming years, it is anticipated to surpass all other countries in terms of cosmetic consumption.
Our Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins. We also offer products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums. All our products adhere to the rigorous standards of the pharmaceutical and cosmetics industries. Additionally, we are involved in the trading of certain packing materials and raw materials used in pharmaceutical and cosmetic products.
Peer Comparison:
- Astonea Labs Limited
- Beta Drugs limited
Astonea Labs Ltd IPO Key Points
Strengths
- Our experienced management and dedicated employee base.
- Scalable business model.
- Wide and diverse range of product offerings.
- Quality Service.
Risk
- The Company has not satisfied the annual OMFUA, under which the FDA assesses and collects fees from qualifying manufacturers of OTC monograph drugs which is mandatory to be paid by all the manufacturers of OTC drugs.
- There have been some instances of delayed and non-filings in the past with the Registrar of Companies which may attract penalties.
- The company is dependent on third parties for the supply of raw materials and such third parties could fails in meeting their obligations, which may have a material adverse effect on its business, results of operations and financial condition. Further its 35.47%, 41.96%, 55.74% and 33.90% of its total purchases are derived from its top 10 suppliers for Financial Years ended on March 31, 2024, March 31, 2023, March 31, 2022 and for the period ended December 31, 2024 respectively.
Strategy
- Expand our scope by adding more products.
- Broaden and deepen presence in existing product portfolio.
- Develop and grow our export division.
- Increase by targeting unexplored markets.
- Leveraging our marketing skills and relationships.
- Our experienced management and dedicated employee base.
- Scalable business model.
- Wide and diverse range of product offerings.
- Quality Service.
How To Apply for Astonea Labs Ltd IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.
